Ultragenyx Pharmaceutical Inc. (RARE) Stock Split History

Ultragenyx Pharmaceutical Inc. has split its stock once since its initial public offering (IPO). The stock split of Ultragenyx Pharmaceutical Inc. occurred on January 17, 2014 on a 15-for-47 basis, meaning that for 47 shares of RARE owned pre-split, shareholders then owned 15 shares.

This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on Ultragenyx Pharmaceutical Inc.'s total market capitalization.

The answer will depend on the decisions of the company's managers and market volatility. Ultragenyx Pharmaceutical Inc. has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when RARE stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Ultragenyx Pharmaceutical Inc.'s board of directors. Typically, no action is taken until its price per share reaches a specific threshold.